Last reviewed · How we verify

NCT03571867

Comparison of The Severity of Agitation of Sugammadex and Atropine-Nesostigmine in Adenotonsillectomy

Status unknown Last updated 28 June 2018
What this trial tests

trial in The Severity of Agitation in Adenotonsillectomy in Pediatric Patients in 70 participants. Status unknown.

Timeline
1 July 2018
Primary endpoint
1 September 2018
1 November 2018

Quick facts

Lead sponsorSakarya University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment70
Start date1 July 2018
Primary completion1 September 2018
Estimated completion1 November 2018
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Sakarya University

Who can join

Adults 5 to 13, any sex, with The Severity of Agitation in Adenotonsillectomy in Pediatric Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the use of sugammadex during the reversal of neuromuscular blocking after adenotonsillectomy surgery in pediatric patients would be advantageous in terms of patient comfort and reducing side effects. Thus, we aimed to evaluate the time to extubation, agitation and pain scores in pediatric patients who underwent adenotonsillectomy and awakened with neostigmine and sugammadex in our study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sakarya University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03571867.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing